We value MU at $677 a share. The report's $878.67 price (Oct 16, 2026) was 30% above fair value: Avoid.
Restated Oct 26, 2026 (method case-spread-2026-10-24); the report's original value was $654, Avoid.
- Five-year return
- 4.8%
- a year, at the report's price
- Return
- +2.8%
- vs SPY
- +2.6%
- vs benchmark
- +2.5%
Close of Oct 16, 2026 to close of Oct 26, 2026
What would change the view
- Micron discloses priced agreements covering 26% or more of FY2031 volume at floors near its prior peak margin: the value crosses the Hold line ($747), where our rule moves from Avoid to Hold.
- Micron amends floor pricing, forfeits or returns customer deposits, or reports floored revenue below its contract path in a quarter of falling prices: the floored share is 0 and the value about $549.
- Contract DRAM prices still rising through the second half of calendar 2028 after ID2 and Yongin Y1 start: the turn is later than FY2029 (a year later is +$78).
- CXMT's DRAM revenue share passes 12% while its capacity reaches 420k wafers a month in 2027: the market normal is below 2.55.
Catalysts
- FY2027 Q1 results (date from the prior vendor calendar, not company-confirmed): any disclosure of floor levels, agreement terms past 2030 or strategic customer agreement (SCA) coverage of FY2028 and later.
- CXMT's capacity against its 420k wafers a month 2027 plan and its DRAM revenue share (TrendForce quarterly): the main push on the market normal.
- Micron ID2 and Hiroshima output, SK hynix Yongin Y1 ramp: the new capacity our model dates the price turn to.
Next results preview
Results expected Dec 16, 2026. No Street figure is stored for these forecasts.
| Metric | Ours | Our range | Street |
|---|---|---|---|
| Revenue ($B, as reported) | 63 | 60 to 66 | none |
| Non-GAAP diluted EPS ($) | 39.5 | 37 to 43 | none |
| Non-GAAP gross margin (%) | 86.5 | 85 to 88 | none |
This text argues the original call. The current figures are at the top.
We rate Micron Avoid, close to a Hold: our fair value is $654 a share against a price of $878.67 (0.74x). Only $314 of that price is cash we can date, the free cash flow of the next two fiscal years plus net cash. The other $565 pays for what Micron earns after the current memory boom, and that is a judgment.
How to read the numbers.
- Cases. The central case is our best estimate. The bear case is a severe but plausible bad outcome and the bull case the matching good one. The central case sets the view; the bear and bull show how far the value could move.
- Markup and the market normal. The markup is Micron's revenue divided by its cash cost of goods sold, so a markup of 2.55 means the memory sells for 2.55 times its cash cost to make. The market normal is the markup we expect memory to earn on average after the shortage ends, outside the contracts below.
- Floors and the floored share. Micron's strategic customer agreements are take-or-pay contracts, mostly in price bands with floors. The floored share is the part of FY2031 volume sold at the floor price instead of the market. At the floor the markup is 4.39 (61% gross margin).
- Fiscal years. Micron's fiscal year ends about 1 September, so FY2031 runs from September 2030 to August 2031.
- The Hold line. $747, the fair value at which our rule would move from Avoid to Hold.
- HBM is high-bandwidth memory, used with AI chips, and CXMT is the Chinese memory maker gaining share.
What this report does
It revises our earlier report of 2026-10-16 (Avoid, $625), which stays on the
record (link). This report answers two
questions Dong asked on 2026-10-17. Was the earlier report anchored too hard
on five specific years? Partly: the year prices turn moves value by about
$78, and the earlier report hid the part of the value we actually know inside
one judged number. And did it weigh what is really different this cycle? It
did not value the one hard difference, the contract floors. This report
values them and splits the price into a dated part and a judged part. The
answer moves only $29, because most of the contracts end before FY2031, the
year the exit price capitalises. The sector note on what is different this
cycle is ../sectors/memory/note.md; its
sources, including the 84 memory bookmarks in Dong's vault, are in
../sectors/memory/data/sources.md.
The price is $314 of dated cash and $565 of judgment
| Part | Per share | How sure |
|---|---|---|
| FY2027-FY2028 free cash flow ($145.0B, $176.3B), at 10.06% | $253 | Guided and contracted: Q1 guide, over 75% of FY2027 output committed, supply "much tighter" in 2027-28 [M] |
| Net cash at 2026-09-03 ($68.3B) | $61 | Reported [F] |
| Dated part | $314 | |
| What the price pays for Micron after the boom | $565 (64% of the price) | The judgment |
([F] marks a reported fact and [M] a management claim.)
The judged part is a question about returns. On this model's path, the central case earns 16.6% after tax on its plant in FY2031; Micron earned 15.4% (net income over net plant) pooled over FY2014-FY2025 and 24.3% in its best cycle, FY2017-FY2022 [F, FMP statements in our 2026-10-15 Micron report]. The price needs about the best cycle, held as normal. That is not an extreme ask, which is why the view sits near the line.
What is really different this cycle, and how much we lean on it
The full ranking is in the sector note, section 2. In short:
- Hard, and valued here: take-or-pay agreements over 35% of revenue through 2030, three quarters with defined pricing, mostly in bands with floors; $32B of customer commitments, mostly cash; the CFO: "even at floor prices, we expect margins meaningfully above any prior cycle peak margins" (Q4 FY2026 call). We take the floor at the old peak, a 61% gross margin, which at this model's FY2031 cost is a cash markup of 4.39.
- Hard, but short: the agreements mostly end in calendar 2030. FY2031 runs September 2030 to August 2031, so about 9% of its volume is inside today's terms; with extensions and new agreements we use 15% (bear 0%, bull 35%).
- Real but partial: HBM takes three to four times the wafers per bit and has three suppliers; demand comes from a few hyperscalers with long plans. These lift the market normal above Micron's long average, not above its best cycle.
- Cutting the other way: CXMT went from 7.6% to 9.5% of DRAM revenue in one quarter (TrendForce) and plans to double its wafers by 2028; SK hynix, Samsung, Micron and CXMT all add cleanrooms in 2028-30; customers already cut memory per server (Micron, Q4 call) and DeepSeek's newest model needs a quarter of the HBM for its cache.
- Not leaned on: "no line of sight to balance" (an outlook; the 2018 and 2022 peaks each fell 34-80 margin points within about six quarters), and Street price paths that never fall (Citi's DRAM path rises to 2031; Bloomberg Intelligence's HBM path implies about $630B of HBM in 2030).
Is a fall from 85% to 41% in three years unprecedented? Not in speed: Micron's quarterly gross margin fell from 47% to -33% in four quarters (2022-23) and from 61% to 27% in five (2018-19). What is new is the height it starts from.
Three cases: $219, $654 and $1,420
| Bear | Central | Bull | |
|---|---|---|---|
| Market normal markup | 2.34 (latest cycle) | 2.55 (between Micron's two histories) | 3.0 (FY2022) |
| FY2031 volume at the floor (4.39) | 0% (renegotiated in a glut) | 15% | 35% (renewed toward management's 50% goal) |
| Blended FY2031 markup | 2.34 | 2.83 | 3.48 |
| FY2031 gross margin | 22.4% | 40.6% | 52.8% |
| FY2031 return on plant | 1.8% | 16.6% | 30.2% |
| Fair value today | $219.18 | $654.30 | $1,419.97 |
| Exit price 2031-08-28 | $38.83 | $530.03 | $1,632.73 |
| Purchase price | $203.92 | $605.18 | $1,309.37 |
| Return a year at the price | -21.0% | 3.1% | 22.1% |
The bear holds a trough as the normal forever (1.8% on plant), which is harsh; it is the case where the new capacity overshoots and the floors are renegotiated. FY2027-FY2028 are the same in every case (the path from our earlier Buy report of 2026-10-16, linked here, which the Q1 guide and the agreements date).
The simulation's median ($779) sits above our central case ($654)
The simulation (5,000 draws, odds.json) has a median of $779 and a mean
of $791, against the central $654; 29% of draws are at or above the price.
The gap is ours by design: both judged inputs have longer tails up than
down. The market normal runs from 2.1 to 3.74 around 2.55, because Micron's
markup has a hard floor in practice (its latest cycle averaged 2.34) but has
reached 3.74; the floored share runs from 0 to 45% around 15%, because the
agreements can be renewed but cannot go below zero. The central case is
our most likely single path; the median says the value is more likely
above it than below. The two straddle the Hold line ($747): the view rule
uses the central case and reads Avoid, but this is close to a Hold, and a
reader who weights the upside tails more than we do will reach one.
Our 10th-90th range ($602-$1,002) is 22% as wide as the Street's targets ($1,200-$3,000). We did not widen it: $314 of the value is dated cash in every draw, and the Street's spread is about whether peak earnings are normalised at all, which we do not treat as uncertain in that direction (a judgment we disclose).
Sensitivities (central, one at a time)
| Change | Fair value |
|---|---|
| Market normal 2.37 / 2.75 / 3.00 / 3.25 | $596 / $730 / $834 / $939 |
| Floored share 0% / 25% / 35% / 50% | $549 / $736 / $826 / $963 |
| Prices turn a year later (FY2030) / earlier (FY2028) | $732 / $587 |
| Capex kept on the earlier report's path, no bend | $622 |
Bridge from the earlier report
| Step | Value |
|---|---|
| Earlier report's central (normal 2.75 for everything, contracts folded in) | $625.43 |
| Take the contract lift out of the market normal (2.75 to 2.55), add 15% at the floor | $654.30 |
The two steps are one change: the contracts move from a reason for the
normal to an explicit input, so they count once. The rest of the engine is
unchanged and the earlier report reruns at $625.43 (output.txt, last
line).
Our $654 is 0.41x the Street's target, and the gap is peak earnings never normalised
Our $654 is 0.41x the Street's average target of $1,588.85 (FMP, 12
targets in the last quarter, horizons absent). Running the Street's own
revenue through our engine (street_path.txt), then letting prices reach
our blended normal of 2.83 by FY2031:
| Step | Value |
|---|---|
| This report's central | $654.30 |
| Street revenue through FY2028 instead of ours | $642.44 (-11.87) |
| Street revenue through FY2029 | $685.65 (+43.21) |
| Street revenue through FY2030 ($497.9B, 8 analysts) | $816.29 (+130.64) |
| The same, ending at 3.11 / 3.50 | $938.56 / $1,116.07 |
| Left to the Street's average | $772.56 |
So the Street's revenue path is not the gap: even its FY2030 revenue, which rises 49% in a year, is worth $816 if prices then reach our normal. The gap is the Street's targets (7.6x its own FY2028 EPS) valuing peak earnings with no normalisation after them. We do not adopt that; it is the same error our earlier Buy report of 2026-10-16 made, which the report we revise corrected.
Why the other side could be right
- The agreements are a new kind of contract, backed by cash. If buyers keep paying the floors past 2030 to secure supply, a floored share of 41% justifies the price, and management's goal is about 50% of revenue under agreements, three quarters priced.
- Micron's best cycle (24% on plant) is the right base if HBM and three suppliers make memory less of a commodity than it was in 2014-2025.
- Prices may turn later than FY2029: Citi's DRAM path rises every year to 2031, and Micron sees 2028 tighter than 2027. A year later is +$78.
What would prove us wrong
The full list is in record.json: the floors disclosed past 2030 (up),
floors amended in a price fall (down to about $549), prices still rising
after Micron's ID2 fab and SK hynix's Yongin Y1 fab start (later turn),
CXMT's share past 12% with 420k wafers in 2027 (lower market normal).
Review: no independent reviewer, so a self-check
No independent reviewer read this report: Dong asked our research lead to do this work alone. We checked it ourselves against the standard checklist for research reports:
| Question | Result |
|---|---|
| Is a peak held as the normal? | No: FY2031 central markup 2.83 against a FY2014-FY2025 maximum of 3.74; supply grows while prices fall |
| Is a decline assumed without a date? | Disclosed: the FY2029 turn is assumed; the capacity dates are dated (sector note T2-T3) |
| Is one downside counted twice? | Fixed from the earlier report: the contracts were a reason for the normal and are now an input, counted once |
| Are the top inputs sourced? | Floor: Q4 call, primary. Floored share: our arithmetic from the call. Market normal: Micron statements. CXMT: trade press |
| What does the price need? (reverse underwrite) | A market normal of 3.11, or 41% floored |
| Not done | Independent review; floor levels (undisclosed); a year-by-year floor in FY2029-FY2030, where the market markups sit near or above it |
Files
model.py → output.txt (cases, two parts, grids); market.py →
market-output.txt; street_path.py → street_path.txt; inputs.json
holds every judgment with its basis; assumptions.md; drivers.json and
odds.json for the simulation.
Details
- Report date
- Oct 16, 2026
- Price source
- Robinhood last regular-session trade; official 2026-10-16 close not yet in the feed when read (re-read 2026-10-17), Oct 16, 2026, 12:59 PM PDT
- Bear / bull
- $213 / $1,575
- Exit price
- $611 (on Aug 28, 2031)
- Confidence
- 50%
- Price against our scenarios
- The price is justified in 20-50% of our scenarios5,000 simulated outcomes, each drawing the uncertain drivers from ranges we chose: our judgement, not a measured chance
- What moves the answer
- the exit price (market outcome) 56%; Micron's normal cash markup (revenue over cash cost of goods) on volume sold at market prices once the shortage ends, reached in FY2031 24%; Share of FY2031 volume sold at or above the contract floor and carried into the exit 7%How much of the spread in value each driver explains on its own; drivers that move together share credit, so the shares need not add to 100%.
- Cost of equity (original)
- 10.1%
- Original figures
- fair value $654 (bear $219, bull $1,420), exit $530; Avoid
- Street
- average $1,589, median $1,500, low $1,200, high $3,000; 12 targets in the last quarter; FMP price-target-consensus, Oct 17, 2026, 7:57 PM PDT
- Restated
- Oct 26, 2026, method case-spread-2026-10-24; forecast.json valued by method.py at market inputs 2026-10-01
- Cost of equity calibration
- +0.0 points
- Calibration source
- none: the 1-point cut set 2026-10-16 to pull the batch toward the Street was removed on 2026-10-18 (Dong); the cost of equity is risk-free plus beta times the premium
- View rule
- strong buy when the price is at or below 0.80x fair value; buy when at or below 0.90x fair value; avoid when fair value is below 0.85x the price; otherwise hold
- Blind step
- Unblinded; the model was committed in 785d340 before the record
- Method
- As of Oct 22, 2026, built without: Mature return holds own capital
Original call, Oct 16, 2026 (before the Oct 26, 2026 restatement)
Revises our earlier report of 2026-10-16 (Avoid, $625), which stays on the record. This report values Micron's take-or-pay agreements explicitly: the CFO says margins at the floor prices sit 'meaningfully above any prior cycle peak' (61%), and the agreements cover over 35% of revenue through 2030, three quarters with defined pricing. They mostly end in calendar 2030, so only about 15% of FY2031 volume, the year the exit price capitalises, is floored in the central case; the rest sells at a market normal markup of 2.55 (revenue as a multiple of cash cost), midway between Micron's FY2014-FY2025 and FY2017-FY2022 histories, with HBM (high-bandwidth memory) pushing up and CXMT (a Chinese memory maker) pushing down. Fair value $654 at a 10.06% cost of equity, purchase price $605, bear $219, bull $1,420, case-weighted $737. Of the $878.67 price, $314 is dated cash (FY2027-FY2028 free cash flow and net cash); the other $565 needs a market normal of 3.11, Micron's best cycle held as normal, or 41% of volume floored. Avoid by the rule, near the line: Hold at a market normal of 2.79 or a floored share of 26%. Fully unblinded (written after the price was known).
As of 2026-10-16 · fully unblinded (written after the price was known) · written 2026-10-17
- Fair value today
- $654 per diluted share (cost of equity 10.06%)
- Price
- $878.67, Robinhood last regular-session trade, 2026-10-16 19:59:59 UTC (official close not yet in the feed when read) → fair value 0.74x the price
- Five-year exit price
- $530 on 2031-08-28 (long fade: returns drifting toward the cost of capital over many years; 10/20 years $518/$541)
- Five-year return
- 3.1% a year at the price, payouts included
- Purchase price
- $605 for the 12% hurdle (the yearly return we require)
- Bear / bull today
- $219 (market 2.34, no floors) / $1,420 (market 3.0, 35% floored)
- Case-weighted value
- $737 at our weights of 25% / 50% / 25%
- Confidence
- Medium: 50% our subjective probability that the exit lands within ±20% of $530
- Dated part
- $314 a share: FY2027-FY2028 free cash flow ($253) and today's net cash ($61)
- Price needs
- $565 for Micron after the boom: a market normal markup of 3.11 with 15% floored (Micron's best cycle averaged 2.77; FY2018 peak 3.74), or 41% of volume floored
- Avoid holds unless
- the market normal is 2.79 or more, or 26% of FY2031 volume is floored; a Buy needs 3.28
- P(price justified)
- 20-50% of our scenarios (subjective, not calibrated); simulated median $779
- Key driver
- The market normal: 2.37 is $596, 2.75 is $730, 3.00 is $834
- Street
- FMP average target $1,588.85 (median $1,500, $1,200-$3,000), captured 2026-10-18 02:57 UTC; horizons and update dates absent; 7.6x the Street's own FY2028 EPS
- Call rests on
- Micron earning about its FY2014-FY2025 average return on plant after 2028, plus the contract floors on the part of FY2031 the agreements still cover